Share Facebook Twitter Email A Taiwenese claims study of patients receiving systemic therapy for cancer reveals a two-fold increase in psoriasis for those on immune checkpoint inhibition with incidence peaking at 6 months on treatment. | To, JAMA Dermatol 2024 skin
